Depomed
Pharmaceuticals, 100 Saunders Rd, Newark, California, 60045, United States, 201-500 Employees
Phone Number: 22********
Who is DEPOMED
Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, pr...
Read More
-
Headquarters: 100 Saunders Rd, Newark, California, 60045, United States
-
Date Founded: 1995
-
Employees: 201-500
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Depomed Org Chart and Mapping
Email
Phone
Similar Companies to Depomed
Assertio
-
11-50
-
$ 50 Million to 100 Million
Dynavax Technologies
-
201-500
-
$ 500 Million to 1 Billion
Egalet Corporation
-
51-200
-
$ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Depomed
Answer: Depomed's headquarters are located at 100 Saunders Rd, Newark, California, 60045, United States
Answer: Depomed's phone number is 22********
Answer: Depomed's official website is https://assertiotx.com
Answer: Depomed's revenue is $100 Million to $250 Million
Answer: Depomed's SIC: 2834
Answer: Depomed's NAICS: 325412
Answer: Depomed has 201-500 employees
Answer: Depomed is in Pharmaceuticals
Answer: Depomed top competitors include: Assertio , Dynavax Technologies , Egalet Corporation
Answer: Depomed contact info: Phone number: 22******** Website: https://assertiotx.com
Answer: Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, providers and in payors through commercialization of products in the areas of pain and neurology, and developing drugs in areas of unmet medical needs. Depomed currently markets three medicines focused on neuropathic pain and migraine through its Neurology and Pain Business and has an emerging Specialty Business focused on orphan drug indications and areas of unmet medical need. Depomed has a clear THREE PILLAR strategy for growth: MAINTAIN a strong/profitable NUCYNTA franchise through a commercialization agreement with Collegium, GROW the Neurology and Pain Business and BUILD a new Specialty Business through a recent Cosyntropin transaction. The companys strategy is to continue to identify, license and develop new products-that offer enhanced therapeutic options to patient populations that may be underserved by existing therapies. As part of the transformation strategy, Depomed will be relocating its headquarters out of California. Information about location will be shared during the interview process. Depomed is listed on the NASDAQ market under the ticker DEPO. Depomed is an AA/EEO/Veterans/Disabled employer.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month